Murine Red & Sore Eyes (Naphazoline Hydrochloride)

Naphazoline hydrochloride acts as a selective alpha‑adrenergic agonist. When applied to the ocular surface, it binds to alpha receptors on conjunctival blood‑vessel smooth muscle, causing vasoconstriction. This reduces blood flow to the superficial vessels, decreasing the visible redness and associated discomfort.

The dosing regimen for Murine Red & Sore Eyes is determined by the prescribing healthcare professional. Typically, one to two drops are instilled into the affected eye(s) no more than three to four times daily, but the exact frequency and duration should follow the prescriber’s instructions.

Safety data for naphazoline hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using this product to weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Murine Red & Sore Eyes contains naphazoline hydrochloride, a fast‑acting alpha‑adrenergic agonist. Compared with other decongestants such as tetrahydrozoline, naphazoline offers a similar onset of action but may have a slightly higher potency, requiring careful adherence to dosing limits to avoid rebound redness.

Store the product at room temperature, ideally below 25 °C, in its original packaging. Protect it from excessive moisture and direct sunlight. Ensure the cap is tightly closed to maintain sterility and potency.

The solution is applied topically to the conjunctival sac. After washing hands, tilt the head back, gently pull down the lower eyelid, and place the prescribed number of drops into the pocket formed. Close the eye briefly to allow even distribution, then avoid blinking excessively.

Serious risks, though rare, include persistent ocular hypertension, severe allergic reactions such as contact dermatitis, and systemic hypertension in susceptible individuals. If any of these occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to naphazoline hydrochloride or any excipients in the formulation should avoid this product. It is also contraindicated for patients requiring continuous use of other ocular vasoconstrictors, as well as those with uncontrolled hypertension without medical supervision.